Filing Details
- Accession Number:
- 0001415889-24-007083
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-06 17:37:37
- Reporting Period:
- 2024-03-04
- Accepted Time:
- 2024-03-06 17:37:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals Ltd. | KNSA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1532218 | K Sanj Patel | C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM 11 | Chairman & Ceo | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Share | Disposition | 2024-03-04 | 9,406 | $21.31 | 73,930 | No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Class A Common Share | Disposition | 2024-03-04 | 3,336 | $22.00 | 70,594 | No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Class A Common Share | Disposition | 2024-03-06 | 5,582 | $21.00 | 65,012 | No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
| No | 4 | S | Indirect | Held by The Anglia 2013 Revocable Trust, u/d/t August 15, 2013 |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Class A Common Share | 109,795 | Indirect | Held by The Marina 2016 Irrevocable Trust, u/d/t June 23, 2016 |
| Class A Common Share | 52,516 | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging between $21.00 and $21.785. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
Billionaire Hedge Funds
